🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Mentalization-based Treatment Versus Bona-fide Treatment for Patients With Borderline Personality Disorder in Germany

RecruitingNAAges 18 Years - 65 YearsAllHeidelberg University
NCT06018272 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Background: Borderline Personality Disorder (BPD) is a serious mental disorder. Mentalization-based treatment (MBT) is one evidence-based treatment for individuals with BPD. Specifically, MBT has been highlighted for its effectiveness in reduction of suicidal and non-suicidal self-injury (NSSI). Yet, randomized-controlled trials (RCT) on MBT in outpatient settings compared with bona fide treatment (BFT) are still scarce and none has been conducted in Germany. The primary objective of this RCT is to investigate whether outpatient MBT is more effective in the reduction of crisis events (incidences of NSSI and suicide attempts) compared with BFT (namely psychodynamic or cognitive-behavioural psychotherapy) in Germany. Secondary, MBT's efficacy will be investigated with regard to cost-effectiveness, general and interpersonal functioning, BPD and general symptom severity, social adjustment, q

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Borderline Personality Disorder * non-suicidal self injury or suicide attempts in the past two years as indicated by the IPDE item "repeated suicidal behaviours, gestures, threats or self-harm", one of which has occurred in the past six months Exclusion Criteria: * acute substance use disorder (exception: cannabis dependency) * diagnosis of schizophrenia or schizotypal personality disorder * bipolar I disorder (DSM-5) * cognitive impairment (IQ\<80) or evidence of organic brain disorder * BMI\<16.5 * serious medical condition that will require hospitalization within the next year (e.g. cancer) * no sufficient German language abilities
💊

What it tests

  • Mentalization-Based Treatment (MBT)
  • Bona-Fide Treatment in Germany (BFT)
📍

Where

5 sites
Psychologische Hochschule Berlin
Berlin, Germany
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Düsseldorf
Düsseldorf, Germany
Heidelberg University
Heidelberg, Germany
Institute for Psychosocial Medicine, Psychotherapy and Psychooncology
Jena, Germany
Clinic for Psychosomatic Medicine and Psychotherapy, University Hospital Ulm
Ulm, Germany
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy